skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
FDA resumes review of Daewoong Pharmaceutical’s Nabota
Date 2018-08-30 Hit 2206
News List
Prev Nabota received approval from Health Canada
Next Daewoong Pharmaceutical leads innovation of local business by focusing on technology transfer with Trapaco, the largest pharmaceuticals company in Vietnam.